MediPharm Labs (TSX:LABS) Inventories, Finished Goods : C$5.65 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Inventories, Finished Goods?

MediPharm Labs's quarterly finished goods increased from Sep. 2023 (C$6.01 Mil) to Dec. 2023 (C$6.42 Mil) but then declined from Dec. 2023 (C$6.42 Mil) to Mar. 2024 (C$5.65 Mil).

MediPharm Labs's annual finished goods declined from Dec. 2021 (C$8.19 Mil) to Dec. 2022 (C$5.55 Mil) but then increased from Dec. 2022 (C$5.55 Mil) to Dec. 2023 (C$6.42 Mil).

MediPharm Labs Inventories, Finished Goods Historical Data

The historical data trend for MediPharm Labs's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Inventories, Finished Goods Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

23.41

11.84

8.19

5.55

6.42

MediPharm Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															5.15	6.99	6.01	6.42	5.65

MediPharm Labs Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

MediPharm Labs (TSX:LABS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Executives

Keith Strachan

Director